Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 135 Pages
Report ld: 6468715
Request Sample
Customized Report
Blood Coagulometers Market Size(US$)

CAGR 2026-2032
9.1%
Market Size,2032
USD 9,407
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Blood Coagulometers market was valued at US$ 5156 million in 2025 and is anticipated to reach US$ 9407 million by 2032, at a CAGR of 9.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood Coagulometers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A blood coagulometer is an analyzer used to test the coagulation efficiency of blood so as to diagnose and assess bleeding disorders such as hemophilia or to monitor patients who are taking anticoagulant medicines such as aspirin, heparin, or warfarin.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Rising incidences of cardiovascular diseases and blood disorders are likely to have a significant impact on the coagulation analyzers market during the forecast period 2022 to 2029. Another important factor driving the expanding usage of coagulation analyzers is growing geriatric population, rising healthcare costs, technological developments, and rising obesity rates. On the other hand, emerging markets and growing reagent rental business will provide significant opportunities for the growth of the coagulation analyzer market throughout the forecast period. Key market players have launched innovative analyzers that are small in size and easy to integrate, triggering the demand for such analyzers to be widely used in various medical facilities. Furthermore, rising awareness in healthcare systems in many parts of the world has also increased the demand for such analyzers. The rapid advancement and optimization of testing facilities is also driving the growth of the industry as a whole. The subsequent proliferation of innovative healthcare facilities, treatment centers, laboratory facilities, and academic institutions has resulted in a significant increase in the demand for such analyzers. Due to the rising number of heart disease and blood disorders, the demand for these analyzers is also increasing. Due to the ease of use and performance features of these analyzers, patients are able to use these analyzers at home to assess their coagulation status. The aforementioned factors are expected to boost the global market growth.
This report delivers a comprehensive overview of the global Blood Coagulometers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Coagulometers. The Blood Coagulometers market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Coagulometers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Coagulometers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood Coagulometers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood Coagulometers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Blood Coagulometers Market Overview
1.1 Product Definition
1.2 Blood Coagulometers by Type
1.2.1 Global Blood Coagulometers Market Value by Type: 2025 vs 2032
1.2.2 Standalone Analysers
1.2.3 Table Top Analysers
1.2.4 Portable Analysers
1.3 Blood Coagulometers by Application
1.3.1 Global Blood Coagulometers Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Global Blood Coagulometers Market Size Estimates and Forecasts
1.4.1 Global Blood Coagulometers Revenue 2021–2032
1.4.2 Global Blood Coagulometers Sales 2021–2032
1.4.3 Global Blood Coagulometers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Blood Coagulometers Market Competition by Manufacturers
2.1 Global Blood Coagulometers Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood Coagulometers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood Coagulometers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood Coagulometers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood Coagulometers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood Coagulometers, Product Types and Applications
2.7 Global Key Manufacturers of Blood Coagulometers, Date of Entry into the Industry
2.8 Global Blood Coagulometers Market Competitive Situation and Trends
2.8.1 Global Blood Coagulometers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood Coagulometers Players Market Share by Revenue
2.8.3 Global Blood Coagulometers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Coagulometers Market Scenario by Region
3.1 Global Blood Coagulometers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood Coagulometers Sales by Region: 2021–2032
3.2.1 Global Blood Coagulometers Sales by Region: 2021–2026
3.2.2 Global Blood Coagulometers Sales by Region: 2027–2032
3.3 Global Blood Coagulometers Revenue by Region: 2021–2032
3.3.1 Global Blood Coagulometers Revenue by Region: 2021–2026
3.3.2 Global Blood Coagulometers Revenue by Region: 2027–2032
3.4 North America Blood Coagulometers Market Facts & Figures by Country
3.4.1 North America Blood Coagulometers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood Coagulometers Sales by Country (2021–2032)
3.4.3 North America Blood Coagulometers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Coagulometers Market Facts & Figures by Country
3.5.1 Europe Blood Coagulometers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood Coagulometers Sales by Country (2021–2032)
3.5.3 Europe Blood Coagulometers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Coagulometers Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Coagulometers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood Coagulometers Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood Coagulometers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Coagulometers Market Facts & Figures by Country
3.7.1 Latin America Blood Coagulometers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood Coagulometers Sales by Country (2021–2032)
3.7.3 Latin America Blood Coagulometers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Coagulometers Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Coagulometers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood Coagulometers Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood Coagulometers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Coagulometers Sales by Type (2021–2032)
4.1.1 Global Blood Coagulometers Sales by Type (2021–2026)
4.1.2 Global Blood Coagulometers Sales by Type (2027–2032)
4.1.3 Global Blood Coagulometers Sales Market Share by Type (2021–2032)
4.2 Global Blood Coagulometers Revenue by Type (2021–2032)
4.2.1 Global Blood Coagulometers Revenue by Type (2021–2026)
4.2.2 Global Blood Coagulometers Revenue by Type (2027–2032)
4.2.3 Global Blood Coagulometers Revenue Market Share by Type (2021–2032)
4.3 Global Blood Coagulometers Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood Coagulometers Sales by Application (2021–2032)
5.1.1 Global Blood Coagulometers Sales by Application (2021–2026)
5.1.2 Global Blood Coagulometers Sales by Application (2027–2032)
5.1.3 Global Blood Coagulometers Sales Market Share by Application (2021–2032)
5.2 Global Blood Coagulometers Revenue by Application (2021–2032)
5.2.1 Global Blood Coagulometers Revenue by Application (2021–2026)
5.2.2 Global Blood Coagulometers Revenue by Application (2027–2032)
5.2.3 Global Blood Coagulometers Revenue Market Share by Application (2021–2032)
5.3 Global Blood Coagulometers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Siemens
6.1.1 Siemens Company Information
6.1.2 Siemens Description and Business Overview
6.1.3 Siemens Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Siemens Blood Coagulometers Product Portfolio
6.1.5 Siemens Recent Developments/Updates
6.2 Instrumentation Laboratory
6.2.1 Instrumentation Laboratory Company Information
6.2.2 Instrumentation Laboratory Description and Business Overview
6.2.3 Instrumentation Laboratory Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Instrumentation Laboratory Blood Coagulometers Product Portfolio
6.2.5 Instrumentation Laboratory Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roche Blood Coagulometers Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Mindray
6.4.1 Mindray Company Information
6.4.2 Mindray Description and Business Overview
6.4.3 Mindray Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Mindray Blood Coagulometers Product Portfolio
6.4.5 Mindray Recent Developments/Updates
6.5 MRC
6.5.1 MRC Company Information
6.5.2 MRC Description and Business Overview
6.5.3 MRC Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MRC Blood Coagulometers Product Portfolio
6.5.5 MRC Recent Developments/Updates
6.6 Helena Laboratories
6.6.1 Helena Laboratories Company Information
6.6.2 Helena Laboratories Description and Business Overview
6.6.3 Helena Laboratories Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Helena Laboratories Blood Coagulometers Product Portfolio
6.6.5 Helena Laboratories Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific Blood Coagulometers Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 ERBA Diagnostics Mannheim
6.8.1 ERBA Diagnostics Mannheim Company Information
6.8.2 ERBA Diagnostics Mannheim Description and Business Overview
6.8.3 ERBA Diagnostics Mannheim Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ERBA Diagnostics Mannheim Blood Coagulometers Product Portfolio
6.8.5 ERBA Diagnostics Mannheim Recent Developments/Updates
6.9 Rayto Life and Analytical Sciences
6.9.1 Rayto Life and Analytical Sciences Company Information
6.9.2 Rayto Life and Analytical Sciences Description and Business Overview
6.9.3 Rayto Life and Analytical Sciences Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Rayto Life and Analytical Sciences Blood Coagulometers Product Portfolio
6.9.5 Rayto Life and Analytical Sciences Recent Developments/Updates
6.10 Nihon Kohden Corporation
6.10.1 Nihon Kohden Corporation Company Information
6.10.2 Nihon Kohden Corporation Description and Business Overview
6.10.3 Nihon Kohden Corporation Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Nihon Kohden Corporation Blood Coagulometers Product Portfolio
6.10.5 Nihon Kohden Corporation Recent Developments/Updates
6.11 Beckman Coulter Inc. (Danaher Corporation)
6.11.1 Beckman Coulter Inc. (Danaher Corporation) Company Information
6.11.2 Beckman Coulter Inc. (Danaher Corporation) Description and Business Overview
6.11.3 Beckman Coulter Inc. (Danaher Corporation) Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beckman Coulter Inc. (Danaher Corporation) Blood Coagulometers Product Portfolio
6.11.5 Beckman Coulter Inc. (Danaher Corporation) Recent Developments/Updates
6.12 Sysmex Corporation
6.12.1 Sysmex Corporation Company Information
6.12.2 Sysmex Corporation Description and Business Overview
6.12.3 Sysmex Corporation Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sysmex Corporation Blood Coagulometers Product Portfolio
6.12.5 Sysmex Corporation Recent Developments/Updates
6.13 Abbott Laboratories
6.13.1 Abbott Laboratories Company Information
6.13.2 Abbott Laboratories Description and Business Overview
6.13.3 Abbott Laboratories Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Abbott Laboratories Blood Coagulometers Product Portfolio
6.13.5 Abbott Laboratories Recent Developments/Updates
6.14 HORIBA Medical
6.14.1 HORIBA Medical Company Information
6.14.2 HORIBA Medical Description and Business Overview
6.14.3 HORIBA Medical Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 HORIBA Medical Blood Coagulometers Product Portfolio
6.14.5 HORIBA Medical Recent Developments/Updates
6.15 DIRUI Industrial
6.15.1 DIRUI Industrial Company Information
6.15.2 DIRUI Industrial Description and Business Overview
6.15.3 DIRUI Industrial Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 DIRUI Industrial Blood Coagulometers Product Portfolio
6.15.5 DIRUI Industrial Recent Developments/Updates
6.16 Seleo
6.16.1 Seleo Company Information
6.16.2 Seleo Description and Business Overview
6.16.3 Seleo Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Seleo Blood Coagulometers Product Portfolio
6.16.5 Seleo Recent Developments/Updates
6.17 Zircon Biotech
6.17.1 Zircon Biotech Company Information
6.17.2 Zircon Biotech Description and Business Overview
6.17.3 Zircon Biotech Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Zircon Biotech Blood Coagulometers Product Portfolio
6.17.5 Zircon Biotech Recent Developments/Updates
6.18 Beijing Succeeder Technology
6.18.1 Beijing Succeeder Technology Company Information
6.18.2 Beijing Succeeder Technology Description and Business Overview
6.18.3 Beijing Succeeder Technology Blood Coagulometers Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Beijing Succeeder Technology Blood Coagulometers Product Portfolio
6.18.5 Beijing Succeeder Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Coagulometers Industry Chain Analysis
7.2 Blood Coagulometers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Coagulometers Production Mode & Process Analysis
7.4 Blood Coagulometers Sales and Marketing
7.4.1 Blood Coagulometers Sales Channels
7.4.2 Blood Coagulometers Distributors
7.5 Blood Coagulometers Customer Analysis
8 Blood Coagulometers Market Dynamics
8.1 Blood Coagulometers Industry Trends
8.2 Blood Coagulometers Market Drivers
8.3 Blood Coagulometers Market Challenges
8.4 Blood Coagulometers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Blood Coagulometers was estimated to be worth US$ 5156 million in 2025 and is projected to reach US$ 9407 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 147
USD 3950.00
(Single User License)
The global Blood Coagulometers market size was US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 109
USD 4250.00
(Single User License)
The global Blood Coagulometers market is projected to grow from US$ 4766 million in 2024 to US$ 8695 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 173
USD 4900.00
(Single User License)
The global market for Blood Coagulometers was estimated to be worth US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 146
USD 3950.00
(Single User License)
The global market for Blood Coagulometers was valued at US$ 4766 million in the year 2024 and is projected to reach a revised size of US$ 8695 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
The global market for Blood Coagulometers was estimated to be worth US$ 5156 million in 2025 and is projected to reach US$ 9407 million, growing at a CAGR of 9.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 147
The global Blood Coagulometers market size was US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 109
The global Blood Coagulometers market is projected to grow from US$ 4766 million in 2024 to US$ 8695 million by 2031, at a CAGR of 9.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 173
The global market for Blood Coagulometers was estimated to be worth US$ 4766 million in 2024 and is forecast to a readjusted size of US$ 8695 million by 2031 with a CAGR of 9.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 146
The global market for Blood Coagulometers was valued at US$ 4766 million in the year 2024 and is projected to reach a revised size of US$ 8695 million by 2031, growing at a CAGR of 9.1% during the forecast period.
Published: 2025-01-13
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now